Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

Ropinirole hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ropinirole hydrochloride and what is the scope of ropinirole hydrochloride freedom to operate?

Ropinirole hydrochloride
is the generic ingredient in three branded drugs marketed by Glaxosmithkline Llc, Prinston Inc, Zydus Pharms Usa Inc, Accord Hlthcare, Alembic Ltd, Orchid Hlthcare, Corepharma, Watson Labs Inc, Glenmark Generics, Sandoz Inc, Wockhardt, West-ward Pharms Int, G And W Labs Inc, Mylan Pharms Inc, Apotex, Actavis Elizabeth, Dr Reddys Labs Ltd, Mylan, and Wockhardt Ltd, and is included in twenty-one NDAs. There are three patents protecting this compound and nine Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Ropinirole hydrochloride has forty-six patent family members in twenty-seven countries.

There are fourteen drug master file entries for ropinirole hydrochloride. Thirty-four suppliers are listed for this compound.

Summary for Generic Name: ropinirole hydrochloride

Drug Master File Entries: see list14
Suppliers / Packagers: see list34
Bulk Api Vendors: see list67
Clinical Trials: see list997
Patent Applications: see list1,592
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ropinirole hydrochloride at DailyMed

Pharmacology for Ingredient: ropinirole hydrochloride

Drug ClassNonergot Dopamine Agonist
Mechanism of ActionDopamine Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics
ropinirole hydrochloride
TABLET;ORAL090135-003Feb 25, 2010ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
ropinirole hydrochloride
TABLET, EXTENDED RELEASE;ORAL200462-003Oct 15, 2012ABRXNoNo► Subscribe► Subscribe
Glaxosmithkline Llc
ropinirole hydrochloride
TABLET;ORAL020658-007Jan 27, 1999ABRXYesNo► Subscribe► Subscribe
Mylan Pharms Inc
ropinirole hydrochloride
TABLET, EXTENDED RELEASE;ORAL200462-001Oct 15, 2012ABRXNoNo► Subscribe► Subscribe
ropinirole hydrochloride
TABLET;ORAL079165-004Feb 7, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus